Skip to main content
SpringerLink
Log in

Klinik der Spätdyskinesien

  • Conference paper
Katatone und dyskinetische Syndrome

  • 30 Accesses

Zusammenfassung

Die zunehmende Verbreitung der Neuroleptika, die Ausweitung ihres Indika tionsspektrums, neuere Erkenntnisse über Begleitwirkungen und die verstärkte Sensibilität von Patienten und Angehörigen gegenüber medikamentösen Nebenwirkungen machen es notwendig, Nutzen und Risiken der Langzeitbehandlung mit Neuroleptika kritisch gegeneinander abzuwägen (Gardos u. Cole 1976; Helmchen 1978; Davis et al. 1980; Gottfries 1981; Hippius u. Klein 1983; Kane 1984; Johnson 1985; Tegeler 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alexopoulos GS (1979) Lack of complaints in schizophrenics with tardive dyskinesia. J Nerv Ment Dis 167:125–127

    Article  PubMed  CAS  Google Scholar 

  • Andreasen NC (1981) Scale for the Assessment of Negative Symptoms (SANS). The Univer sity of Iowa, Iowa City

    Google Scholar 

  • Baldessarini RJ (1985) Clinical and epidemiologic aspects of tardive dyskinesia. J Clin Psychiatry 46:8–13

    PubMed  CAS  Google Scholar 

  • Barnes TRE, Braude WM (1984) Persistent akathisia associated with early tardive dyskinesia. Postgrad Med J 60:359–361

    Article  PubMed  CAS  Google Scholar 

  • Barnes TRE, Trauer T (1982) Reliability and validity of a tardive dyskinesia videotape rating technique. Brit J Psychiatry 140:508–515

    Article  CAS  Google Scholar 

  • Bartels M, Themelis (1983) Computerized tomography in tardive dyskinesia. Arch Psychiatr Nervenkr 233:371–379

    Article  PubMed  CAS  Google Scholar 

  • Bartels M, Riffel D, Stöhr M (1982) Tardive Dystonie: Eine seltene Nebenwirkung nach Neuroleptika-Langzeitbehandlung. Nervenarzt 53:674–676

    PubMed  CAS  Google Scholar 

  • Bergen JA, Griffiths DA, Rey JM, Beumont JV (1984) Tardive dyskinesia: Fluctuating patient or fluctuating rater. Br J Psychiatry 144:498–502

    Article  PubMed  CAS  Google Scholar 

  • Branchey MC, Branchey LB, Richardson MA (1981) Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients. Am J Psychiatry 138:608–612

    PubMed  CAS  Google Scholar 

  • Brücher K (1982) Die Spätdyskinesien -Eine Übersicht über Klinik, Pathogenese, Prophylaxe und Therapie eines späten neuroleptischen Seiteneffekts. Fortschr Neurol Psychiat 50:138–199

    Google Scholar 

  • Burke RE, Fahn S, Lankowic J (1982) Tardive dystonia: Late onset and persistent dystonia caused by antipsychotic drugs. Neurology 32:1335–1346

    PubMed  CAS  Google Scholar 

  • Casey DE (1985 a) Spontaneous and tardive dyskinesia: Clinical and laboratory studies. J Clin Psychiatry 46:42–47

    PubMed  CAS  Google Scholar 

  • Casey DE (1985 b) Tardive dyskinesia: Reversible and irreversible. In: Casey DE, ChaseTN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacol-ogy, Suppl 2. Springer, Berlin Heidelberg New York Tokyo

    Chapter  Google Scholar 

  • Casey DE, Chase TN, Christensen AV, Gerlach J (1985) Dyskinesia research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Chiang E, Pitts WM, Rodriguez-Garcia M (1985) Respiratory dyskinesia: Review and case reports. J Clin Psychiatry 46:232–234

    PubMed  CAS  Google Scholar 

  • Chouinard G, Annable L, Ross-Chouinard A, Nostores JN (1979) Factors related to tardive dyskinesia. Am J Psychiatry 136:79–83

    PubMed  CAS  Google Scholar 

  • Christensen AV, Greil W, Haag H et al. (1986) Animal models for assessing extrapyramidal-motor side-effects of neuroleptics. Pharmacopsychiatria 19:149–151

    Article  Google Scholar 

  • Crane G (1968) Tardive dyskinesia in patients treated with major neuroleptics: A review of the literature. Am J Psychiatry 124:40–48

    Google Scholar 

  • Crane G (1972) Pseudoparkinsonmism and tardive dyskinesia. Arch Neurol 27:426–430

    Article  PubMed  CAS  Google Scholar 

  • Csernansky JG, Grabowski K, Cervantes J, Kaplan J, Yesavage JA (1981) Fluphenazine decanoate and tardive dyskinesia: A possible association. Am J Psychiatry 138:1362–1365

    PubMed  CAS  Google Scholar 

  • Davis JM, Schaffer CM, Killian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6:70–87

    PubMed  CAS  Google Scholar 

  • Davis KL, Berger PA, Hollister LE (1976) Tardive dyskinesia and depressive illness. Psychopharmacol Commun 2:125–130

    PubMed  CAS  Google Scholar 

  • Degkwitz R, Luxemburger O (1965) Das terminale extrapyramidale Insuffizienz-bzw. De-fektsyndrom infolge chronischer Anwendung von Neuroleptika. Nervenarzt 36:173–175

    Google Scholar 

  • Degkwitz R, Binsack KF, Herkert H, Luxemburger O, Wenzel W (1966) Zum Problem der terminalen extrapyramidalen Hyperkinesen anhand von 1600 langfristig mit Neuroleptika Behandelten. Arzneimittelforsch 16:276–279

    PubMed  CAS  Google Scholar 

  • Ekbom K, Lindholm H, Ljundberg L (1972) New dystonic syndrom associated with butyrophenone therapy. J Neurol 202:94–103

    Article  CAS  Google Scholar 

  • Ezrin Waters C, Seeman MV, Seeman P (1981) Tardive dyskinesia in schizophrenic out patients: Prevalence and significant variables. J Clin Psychiatry 42:16–22

    Google Scholar 

  • Faheem AD, Brightwell DR, Burton GC, Struss A (1982) Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: Tardive dyskinesia? Am J Psychiatry 139:517–518

    PubMed  CAS  Google Scholar 

  • Fairbairn AF, Rowell FJ, Hui SM, Hassanyeh F, Robinson AJ, Eccleston D (1983) Serum concentration of depot neuroleptics in tardive dyskinesia. Br J Psychiatry 142:579–583

    Article  PubMed  CAS  Google Scholar 

  • Famuyiwa OO, Eccleston D, Donaldson AA, Garside RF (1979) Tardive dyskinesia and dementia. Br J Psychiatry 135:500–504

    Article  PubMed  CAS  Google Scholar 

  • Fann WE, Stafford JR, Malone RL, Frost JD, Richman BW (1980) Clinical research techniques in tardive dyskinesia. Am J Psychiatry 134:759–762

    Google Scholar 

  • Firth WR, Ardern MH (1985) Measuring abnormal movement in tardive dyskinesia: A pilot study. Brit J Psychiatry 147:723–726

    Article  CAS  Google Scholar 

  • Gardos G, Cole JO (1976) Maintenance antipsychotic therapie: Is the cure worse than the disease? Am J Psychiatry 133:32–36

    PubMed  CAS  Google Scholar 

  • Gardos G, Cole JO (1983) Tardive dyskinesia and anticholinergic drugs. Am J Psychiatry 140:200–202

    PubMed  CAS  Google Scholar 

  • Gardos G, Cole JO, La Brie R (1977) The assessment of tardive dyskinesia. Arch Gen Psychiatry 34:1206–1212

    Article  PubMed  CAS  Google Scholar 

  • Gelenberg AJ (1976) Computerized tomography in patients with tardive dyskinesia. Am J Psychiatry 133:578–579

    PubMed  CAS  Google Scholar 

  • Gerlach J (1975) Pathophysiological mechanism underlying tardive dyskinesia. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Gerlach J (1977) The relationship between parkinsonism and tardive dyskinesia. Am J Psychiatry 134:781–784

    PubMed  CAS  Google Scholar 

  • Gerlach J (1979) Tardive dyskinesia. Dan Med Bull 26:209–245

    PubMed  CAS  Google Scholar 

  • Gerlach J, Korsgaard S (1983) Classification of abnormal involuntary movements in psychiatric patients. Neuropsychiatr Clin 2:201–208

    Google Scholar 

  • Gerlach J, Thorsen K (1976) The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int Pharmacol Psychiatry 11:1–7

    CAS  Google Scholar 

  • Gibson AC (1981) Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection. Acta Psychiat Scand (Suppl 291) 63:111–114

    Article  Google Scholar 

  • Goldberg SC, Shenoy RS, Julius D, Hamer RM, Ross B, Minton T, Spiro M (1982) Do long-acting injectable neuroleptics protect against tardive dyskinesia? Psychopharmacol Bull 18:177–179

    PubMed  CAS  Google Scholar 

  • Gottfries CG (1981) Long-term neuroleptic treatment benefits and risks. Acta Psychiat Scand (Suppl 291) 63:75–88

    Google Scholar 

  • Granacher RP (1981) Differential diagnosis of tardive dyskinesia: An overview. Am J Psychiatry 138:1288–1297

    PubMed  Google Scholar 

  • Greil W, Haag H, Rossnagl G, Rüther E (1984) Effect of anticholinergics on tardive dyskinesia. Br J Psychiatry 145:304–310

    Article  PubMed  CAS  Google Scholar 

  • Haag H, Greil W, Rüther E (1987) Zusammenhang zwischen Spätdyskinesie und verschiedenen Variablen der neuroleptischen Behandlung. In: Heinrich K, Klieser E (Hrsg) Probleme der neuroleptischen Dosierung. Schattauer, Stuttgart

    Google Scholar 

  • Haddenbrock S (1964) Hyperkinetische Dauersyndrome nach hochdosierter und Langstreckenbehandlung mit Neuroleptika. In: Kranz H, Heinrich K (Hrsg) Begleitwirkungen und Mißerfolge der psychiatrischen Pharmakotherapie. Thieme, Stuttgart

    Google Scholar 

  • Hansen TE, GlazerWM, Moore DC (1986) Tremor and tardive dyskinesia. J Clin Psychiatry 47:461–464

    PubMed  CAS  Google Scholar 

  • Heinrich K, Tegeler J (1983) Dyskognitive, apathische und extrapyramidale Syndrome bei Langzeit-Neurolepsie. In: Hippius H, Klein HE (Hrsg) Therapie mit Neuroleptika. Perimed, Erlangen

    Google Scholar 

  • Heinrich K, Wegener I, Bender HJ (1968) Späte extrapyramidale Hyperkinesen bei neuroleptischer Langzeittherapie. Pharmacopsychiatria 1:169–195

    Article  Google Scholar 

  • Helmchen H (1978) Forschungsaufgaben bei psychiatrischer Langzeitmedikation. Nervenarzt 49:534–538

    PubMed  CAS  Google Scholar 

  • Hippius H, Klein HE (1983) Therapie mit Neuroleptika. Perimed, Erlangen

    Google Scholar 

  • Hippius H, Lange G (1970) Zur Problematik der späten extrapyramidalen Hyperkinesen nach langfristiger neuroleptischer Therapie. Arzneimittelforsch 20:888–889

    PubMed  CAS  Google Scholar 

  • Jeste DV, Wyatt RJ (1981) Changing epidemiology of tardive dyskinesia: An overview. Am J Psychiatry 138:297–309

    Article  PubMed  CAS  Google Scholar 

  • Jeste DV, Wyatt RJ (1982) Understanding and treating tardive dyskinesia. Guilford, New York

    Google Scholar 

  • Jeste DV, Potkin SG, Sindha S, Feder S, Wyatt RJ (1979) Tardive dyskinesia: Reversible and persistent. Arch Gen Psychiatry 36:585–590

    Article  PubMed  CAS  Google Scholar 

  • Jeste DV, Rosenblatt JE, Wagner RL, Wyatt RJ (1979) High serum neuroleptic levels in tar dive dyskinesia? N Engl J Med 301:1184–1186

    PubMed  CAS  Google Scholar 

  • Jeste DV, Wagner RL, Weinberger DR, Rieth KJ, Wyatt RJ (1980) Evaluation of CTscans in tardive dyskinesia. Am J Psychiatry 137:247–249

    PubMed  CAS  Google Scholar 

  • Jeste DV, Karson CN, lager AC, Bigelow LB, Wyatt RJ (1984) Association of abnormal involuntary movements and negative symptoms. Psychopharmacol Bull 20:380–381

    PubMed  CAS  Google Scholar 

  • Johnson DAW (1985) Antipsychotic medication: Clinical guidelines for maintenance therapy. J Clin Psychiatry 46:6–15

    PubMed  CAS  Google Scholar 

  • Jus A, Jus K, Fontaine P (1979) Longterm treatment of tardive dyskinesia. J Clin Psychiatry 40:72–77

    PubMed  CAS  Google Scholar 

  • Kalachnik JE, Young RC, Offerman D (1984) A tardive dyskinesia evaluation and diagnosis form for applied facilities. Psychopharmacol Bull 20:303–307

    PubMed  CAS  Google Scholar 

  • Kane JM (1984) The use of depot neuroleptics: Clinical experience in the United States. J Clin Psychiatry 45:5–12

    PubMed  CAS  Google Scholar 

  • Kane JM, Smith JM (1982) Tardive dyskinesia prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39:473–481

    Article  PubMed  CAS  Google Scholar 

  • Kane JM, Woerner M, Lieberman J (1985) Tardive dyskinesia: Prevalence, incidence and risk factors. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmalogy, Suppl 2. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B (1984) Incidence of tardive dyskinesia: Five-year data from a prospective study. Psychopharmacol Bull 20:39–40

    PubMed  CAS  Google Scholar 

  • Kennedy PF, Hershon HJ, McGuire RJ (1971) Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry 118:509–518

    Article  PubMed  CAS  Google Scholar 

  • Kidger T, Barnes RE, Trauer T, Taylor PJ (1980) Sub-syndromes of tardive dyskinesia. Psychol Med 10:513–520

    Article  PubMed  CAS  Google Scholar 

  • Klawans HL (1983) Symposium on tardive dyskinesia. Clin Neuropharmacol 6:75–168

    Article  Google Scholar 

  • Klawans HL, Goetz CG, Perlik S (1980) Tardive dyskinesia. Review and update. Am J Psychiatry 137:900–908

    PubMed  CAS  Google Scholar 

  • Kraepelin E (1913) Psychiatrie, 8. Aufl. Barth, Leipzig

    Google Scholar 

  • Levine J, Schooler NR, Severe J et al. (1980) Discontinuation of oral and depotfluphenazine in schizophrenic patients after one year of continuous medication. Adv Biochem Psychopharmacol 22:483–493

    Google Scholar 

  • Lieberman J, Kane JM, Woerner M, Weinhold P, Basavaraju N, Kurucz J, Bergmann K (1984) Prevalence of tardive dyskinesia in elderly samples. Psychopharmacol Bull 20:382–386

    PubMed  CAS  Google Scholar 

  • Mallya A, Jose C, Baig M, Williams R, Cho D, Mehta D, Volavka J (1979) Antiparkinsonics, neuroleptics and tardive dyskinesia. Biol Psychiatry 14:645–649

    PubMed  CAS  Google Scholar 

  • Marsden CD (1985) Is tardive dyskinesia a unique disorder? In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Marsden CD,Tarsy D, Baldessarini RJ (1975) Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D (eds) Psychiatric aspects of neurologic disease. Grune & Stratton, New York

    Google Scholar 

  • Munetz MR, Cornes CL (1982) Akathisia, pseudoakathisia and tardive dyskinesia: Clinical examples. Compr Psychiatry 23:345–348

    Article  PubMed  CAS  Google Scholar 

  • Nasrallah HA (1980) Neuroleptic plasma levels and tardive dyskinesia: A possible link? Schizophr Bull 6:4–7

    PubMed  CAS  Google Scholar 

  • Owens DGC, Johnstone EC, Frith CD (1982) Spontaneous involuntary disorders of move ment in neuroleptic treated and untreated chronic schizophrenics. Arch Gen Psychiatry 39:452–461

    Article  PubMed  CAS  Google Scholar 

  • Owens DGC, Johnstone EC, Crow DJ, Frith CD, Jagon JR, Kreel L (1985) Lateral ventricular size in schizophrenia: Relationship to the disease process and its clinical manifestations. Psychol Med 15:27–41

    Article  PubMed  CAS  Google Scholar 

  • Richardson MA, Craig TJ (1982) The coexistence of parkinsonismlike symptoms and tardive dyskinesia. Am J Psychiatry 139:341–343

    PubMed  CAS  Google Scholar 

  • Rosen AM, Mukherjee S, Olarte S, Varia V, Cardenas C (1982) Perception of tardive dyskinesia in outpatients receiving maintenance neuroleptics. Am J Psychiatry 139:372–373

    PubMed  CAS  Google Scholar 

  • Rosenbaum KM, Niven RG, Hanson NP, Swanson DW (1977) Tardive dyskinesia: Relationship with primary affective disorder. Dis Nerv Syst 38:423–427

    PubMed  CAS  Google Scholar 

  • Rüther E, Bindig R, Ther P (1978) Neuropharmakotherapie dyskinetischer Syndrome. Pharmakotherapie 1:200–210

    Google Scholar 

  • Rüther E, Haag M, Oefele K von, Kettler E, Haag H (1987) Späte extrapyramidale Hyperkinesen (Spätdyskinesien): Risiko der Neurolepsie? In: Pichot P, Möller HJ (Hrsg) Neuroleptika Rückschau 1952–1986. Künftige Entwicklungen. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:86–87

    Article  Google Scholar 

  • SeelerW, Kulhanek F (1980) Späte extrapyramidale Hyperkinesen. Schwarzeck, München

    Google Scholar 

  • Simpson GM, Lee JH, Zoubak B, Gardos G (1979) A rating scale for tardive dyskinesia. Psychopharmacology 64:171–179

    Article  PubMed  CAS  Google Scholar 

  • Smith JM, Baldessarini RJ (1980) Changes in prevalence, severity and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 37:1368–1373

    Article  PubMed  CAS  Google Scholar 

  • Smith JM, Kucharski LT, Eblen C, Knutsen E, Linn C (1979) An assessment of tardive dyskinesia in schizophrenic outpatients. Psychopharmacology 64:99–104

    Article  PubMed  CAS  Google Scholar 

  • Sprague RL, Kalachnik JE, Breuning SE et al. (1984) The dyskinesia identification system -Coldwater (Dis-Co): A tardive dyskinesia rating scale for the developmentally disabled. Psychopharmacol Bull 20:318–338

    Google Scholar 

  • Struve FA, Willner AE (1983) Cognitive dysfunction and tardive dyskinesia. Br J Psychiatry 143:597–600

    Article  PubMed  CAS  Google Scholar 

  • Task Force Report (1980) Task Force on the late neurological effects of antipsychotic drugs: Tardive dyskinesia: Summary of a Task Force Report of the American Psychiatric Association. Am J Psychiatry 137:1163–1172

    Google Scholar 

  • Tegeler J (1987 a) Depot-Neuroleptika und späte extrapyramidale Hyperkinesen. In: Heinrich K, Sieberns S (Hrsg) Internationales Fluanxol-Depot-Symposium. Das Ärztliche Gespräch. pmi-Verlag, Frankfurt

    Google Scholar 

  • Tegeler J (1987 b) Nutzen und Risiken der neuroleptischen Langzeitmedikation schizophrener Erkrankungen. In: Kretschmar C (Hrsg) Fragen zur Schizophrenie. Organon, München

    Google Scholar 

  • Tegeler J, Wöller W (1983) Therapeutische Maßnahmen bei späten extrapyramidalen Hyperkinesen. Fortschr Neurol Psychiat 51:203–226

    Article  PubMed  CAS  Google Scholar 

  • Tegeler J, Bogerts B,Wurthmann C (1988a) CT-Untersuchungen an schizophrenen Patienten mit späten Hyperkinesen. In: Beckmann H, Laux D (Hrsg) Biologische Psychiatrie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Tegeler J, Strauss WH, Lüthcke H, Bertling R (1988 b) Cognitive functions in schizophrenic patients with tardive dyskinesia. Pharmacopsychiatria 21:308–309

    Article  CAS  Google Scholar 

  • Tepper S, Haas J (1979) Prevalence of tardive dyskinesia. J Clin Psychiatry 40:508–516

    PubMed  CAS  Google Scholar 

  • Toenniessen LM, Casey DE, McFarland BH (1985) Tardive dyskinesia in the aged. Arch Gen Psychiatry 42:278–284

    Article  PubMed  CAS  Google Scholar 

  • Villeneuve A (1972) The rabbit-syndrome: A peculiar extrapyramidal reaction. Can Psychiatr Ass J (Suppl 2) 17:69–72

    Google Scholar 

  • Waddington JL, Youssef HA, Molloy AG, O’Boyle KM, Pugh MT (1985) Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: Clinical and animal studies. J Clin Psychiatry 46:29–33

    PubMed  CAS  Google Scholar 

  • Wegner JT, Kane JM, Weinhold P, Woerner M, Kinon B, Lieberman J (1985) Cognitive impairment in tardive dyskinesia. Psychiat Res 16:331–337

    Article  CAS  Google Scholar 

  • Weiner WJ, Goetz CG, Nausieda PA, Klawans HL (1978) Respiratory dyskinesias: ex trapyramidal dysfunction and dyspnea. Ann Int Med 88:327–331

    PubMed  CAS  Google Scholar 

  • Williams AO, Reveley MA, Kolakowska T, Ardern M, Mandelbrote BM (1985) Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance. Br J Psychiatry 146:239–246

    Article  PubMed  CAS  Google Scholar 

  • Wöller W, Tegeler J (1983) Späte extrapyramidale Hyperkinesen, Klinik -Prävalenz Pathophysiologie. Fortschr Neurol Psychiat 51:131–157

    Article  PubMed  Google Scholar 

  • Yassa R, Nair V, Dimitry R (1986) Prevalence of tardive dystonia. Acta Psychiat Scand 73:629–633

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Tegeler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Klinik und Poliklinik der Universität München, Nußbaumstraße 7, D-8000, München 2, Deutschland

    Hanns Hippius (Direktor der Psychiatrischen Klinik und Poliklinik der Universität München) (Direktor der Psychiatrischen Klinik und Poliklinik der Universität München)

  2. Psychiatrischen Klinik der Universität Göttingen, v.-Siebold-Straße 5, D-3400, Göttingen, Deutschland

    Eckart Rüther (Direktor der Psychiatrischen Klinik der Universität Göttingen) (Direktor der Psychiatrischen Klinik der Universität Göttingen)

  3. Psychiatrische Klinik und Poliklinik der Universität München, Nußbaumstraße 7, D-8000, München 2, Deutschland

    Max Schmauss (Oberarzt) (Oberarzt)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Tegeler, J. (1989). Klinik der Spätdyskinesien. In: Hippius, H., Rüther, E., Schmauss, M. (eds) Katatone und dyskinetische Syndrome. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83654-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83654-1_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50501-3

  • Online ISBN: 978-3-642-83654-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation